한글목차

세계의 의약품 제조용 디지털 트윈 기술 시장은 2034년까지 CAGR 31.3%로 성장할 것으로 예측됩니다.

헬스케어 IoT의 채택 증가와 의약품 제조 기술의 진보가 시장 성장을 촉진하는 주요 요인

중요한 촉진요인으로는 헬스케어 분야에서의 AI 통합과 의약품 공급망에서 디지털 트윈의 활용이 확대되고 있는 점을 꼽을 수 있습니다. 생명과학 분야에서는 자연어 처리(NLP), 그래프 데이터베이스, API 등의 기술을 통합한 디지털 트윈을 개발하여 데이터베이스 피드백, 데이터 수집 기능 및 개입을 제공함으로써 의료 성과를 개선하고 의료 비용을 절감하는 데 기여하고 있습니다. 디지털 기술은 백신 개발 프로세스 전반에 걸쳐 중요한 역할을 하며, 병원체 식별부터 인체 임상시험까지 보다 신속하고 안전한 백신 제조를 촉진합니다. 데이터베이스 디지털 트윈의 발전은 특히 백신 제조 공정을 강화합니다.

시장 성장에는 대기업의 진입과 프랑스의 Sim&Cure와 같은 신생 기업의 등장으로 더욱 박차를 가하고 있으며, Sim&Cure는 뇌혈전이나 뇌졸중으로 이어질 수 있는 뇌동맥류를 가상으로 치료할 수 있는 Sim&Size와 같은 솔루션을 제공합니다. 이러한 기술에 대한 투자 증가는 보급과 시장 확대를 촉진할 것으로 예상됩니다. 디지털 트윈 기술 확산에는 정부 구상도 중요한 역할을 하고 있습니다. 예를 들어 유럽 정부의 DigiTwins 프로젝트는 오믹스, 컴퓨팅, 커뮤니케이션, 센싱과 같은 첨단 기술을 통해 헬스케어에 혁명을 일으키기 위해 막대한 자금 지원을 받고 있습니다. 마찬가지로 영국 연구혁신청(UK Research and Innovation Agency)과 같은 기관의 구상도 디지털 트윈과 디지털 허브를 포함한 혁신적인 헬스케어 기술을 지속적 으로 지원하고 있습니다.

세계의 의약품 제조용 디지털 트윈 기술의 시장을 조사했으며, 시장 개요, 시장 성장에 대한 영향요인 및 시장 기회 분석, 시장 규모 추이·예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 리포트 개요

제2장 개요

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
• 영향 분석
  • 시장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
• 공급망 분석
• 규제 프레임워크
• 신흥 시장과 메가동향
• Porter's Five Forces 분석
• PEST 분석

제4장 의약품 제조용 디지털 트윈 기술 시장 분석 : 컴포넌트별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이·예측
• 소프트웨어
• 서비스
  • 시장 규모 추이·예측 : 지역별
  • 시장 점유율 : 지역별

제5장 의약품 제조용 디지털 트윈 기술 시장 분석 : 용도별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이·예측
• 자산관리
• 맞춤형 의료
• Drug Discovery
• 기타
  • 시장 규모 추이·예측 : 지역별
  • 시장 점유율 : 지역별

제6장 의약품 제조용 디지털 트윈 기술 시장 분석 : 최종사용자별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이·예측
• 제약·바이오 제약 기업
• 연구·학술기관
• 기타
  • 시장 규모 추이·예측 : 지역별
  • 시장 점유율 : 지역별

제7장 의약품 제조용 디지털 트윈 기술 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추이·예측

제8장 북미의 의약품 제조용 디지털 트윈 기술 시장의 분석

제9장 유럽의 의약품 제조용 디지털 트윈 기술 시장의 분석

제10장 아시아태평양의 의약품 제조용 디지털 트윈 기술 시장의 분석

제11장 라틴아메리카의 의약품 제조용 디지털 트윈 기술 시장의 분석

제12장 중동 및 아프리카의 의약품 제조용 디지털 트윈 기술 시장의 분석

제13장 기업 개요

• 경쟁 구도
• 전략적 전망
• ATOS
• Microsoft
• Philips Healthcare
• Oracle
• PTC
• Verto Health
• Dassault Systems(3DS System)
• ThoughtWire
• Faststream Technologies
• Twin Health
• Siemens Healthineers AG
• GE Healthcare
• ANSYS, INC.
• NVIDIA

제14장 결론·제안

• Visiongain으로부터의 결론
• 시장 참여 기업에 대한 제안

영문목차

The global Digital Twin Technology in Pharmaceutical Manufacturing market is projected to grow at a CAGR of 31.3% by 2034

The Digital Twin Technology in Pharmaceutical Manufacturing Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Adoption of Healthcare IoT and Advancements in Pharmaceutical Manufacturing Technology are Key Factors Propelling Market Growth

Significant drivers include the integration of AI in healthcare and the expanding utilization of digital twins within pharmaceutical supply chains. In life sciences, the incorporation of technologies such as natural language processing (NLP), graph databases, and APIs to develop digital twins contributes to enhanced medical outcomes and reduced healthcare costs by offering data-driven feedback, data gathering capabilities, and interventions. Digital technology plays a crucial role throughout the vaccine development process, facilitating faster and safer vaccine production, from pathogen identification to human clinical trials. Advances in data-driven digital twins specifically enhance vaccine manufacturing processes.

Market growth is further spurred by the entry of major players and the rise of startups, such as Sim&Cure in France, offering solutions like Sim&Size for virtual treatment of brain aneurysms, which can lead to brain clots and strokes. Increased investment in these technologies is anticipated to drive widespread adoption and market expansion. Government initiatives also play a pivotal role in promoting digital twin technologies. For instance, the European Government's DigiTwins project aims to revolutionize healthcare through advanced technologies like omics, computing, communication, and sensing, with substantial funding support. Similarly, initiatives by organizations like the UK Research and Innovation Agency continue to support innovative healthcare technologies, including digital twins and digital hubs.

The adoption of advanced technologies like machine learning, AI, cloud computing, IoT, and big data analytics by major market players enables the creation of robust digital twin solutions, facilitating realistic digital replicas of physical assets. This technological advancement replaces manual systems with industrial and automation solutions, enhancing factory productivity and flexibility

Interoperability Challenges and Data Theft Concerns Likely to Hamper Industry Growth

Industry growth faces challenges such as interoperability issues and concerns over data security breaches, which require significant investment in infrastructure maintenance. Costs associated with implementing virtual twins for large-scale industrial facilities also pose financial barriers to market expansion. Addressing these challenges through continuous product innovation, education, and technological upgrades in pharmaceutical manufacturing processes can significantly accelerate the adoption and growth of digital twin technology within the pharmaceutical manufacturing market.

What Questions Should You Ask before Buying a Market Research Report?

How is the digital twin technology in pharmaceutical manufacturing market evolving?

What is driving and restraining the digital twin technology in pharmaceutical manufacturing market?

How will each digital twin technology in pharmaceutical manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each digital twin technology in pharmaceutical manufacturing submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading digital twin technology in pharmaceutical manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the digital twin technology in pharmaceutical manufacturing projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of digital twin technology in pharmaceutical manufacturing projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the digital twin technology in pharmaceutical manufacturing market?

Where is the digital twin technology in pharmaceutical manufacturing market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the digital twin technology in pharmaceutical manufacturing market today, and over the next 10 years:

Our 276-page report provides 95 tables, 158 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising digital twin technology in pharmaceutical manufacturing prices and recent developments.

Segments Covered in the Report

Component Outlook

Software

Service

Applications Outlook

Asset and Process Management

Personalized Medicine

Drug Discovery

Others

End-use Outlook

Pharma & Bio-pharma Companies

Research & Academics

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles for some of the leading companies in the Digital Twin Technology in Pharmaceutical Manufacturing Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

ANSYS, INC.

Atos

Dassault Systems (3DS System)

Faststream Technologies

GE Healthcare

Microsoft

NVIDIA

Oracle

Philips Healthcare

PTC

Siemens Healthineers AG

ThoughWire

Twin Health

Verto Healthcare

Overall world revenue for Digital Twin Technology in Pharmaceutical Manufacturing Market, 2024 to 2034 in terms of value the market will surpass US$300 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Digital Twin Technology in Pharmaceutical Manufacturing Market, 2024 to 2034 report help you?

In summary, our 270+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Digital Twin Technology in Pharmaceutical Manufacturing Market, 2024 to 2034, with forecasts for component, application, end-use each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Digital Twin Technology in Pharmaceutical Manufacturing Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Digital Twin Technology in Pharmaceutical Manufacturing Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Digital Twin Technology in Pharmaceutical Manufacturing Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Digital Twin Technology in Pharmaceutical Manufacturing Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
• 3.3 Impact Analysis
  • 3.3.1 Market Driving Factors
    • 3.3.1.1 Growing Applications of Digital Twin Technology in Pharmaceutical Industry
    • 3.3.1.2 Introduction of Industry 4.0
    • 3.3.1.3 Increasing Complexity of Drug Formulations
  • 3.3.2 Market Restraining Factors
    • 3.3.2.1 Data Theft and Management Concerns
    • 3.3.2.2 Lack of Skilled Personnel
    • 3.3.2.3 Interoperability Challenges
    • 3.3.2.4 Regulatory Hurdles
  • 3.3.3 Market Opportunities
    • 3.3.3.1 Technology Development
    • 3.3.3.2 Increase in Funding from Government and Non-government Sources
• 3.4 Supply Chain Analysis
• 3.5 Regulatory Framework
• 3.6 Emerging Markets and Megatrends
• 3.7 Porter's Five Forces Analysis
  • 3.7.1 Bargaining Power of Suppliers
  • 3.7.2 Bargaining Power of Buyers
  • 3.7.3 Competitive Rivalry
  • 3.7.4 Threat from Substitutes
  • 3.7.5 Threat of New Entrants
• 3.8 PEST Analysis

4 Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis by Components

• 4.1 Key Findings
• 4.2 Components Segment: Market Attractiveness Index
• 4.3 Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Indication
• 4.4 Software
  • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 Services
  • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis by Application

• 5.1 Key Findings
• 5.2 Application Segment: Market Attractiveness Index
• 5.3 Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Application
• 5.4 Asset Management
  • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Personalized Medicine
  • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 Drug Discovery
  • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)
• 5.7 Others
  • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.7.2 Market Share by Region, 2024 & 2034 (%)

6 Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis by End-use

• 6.1 Key Findings
• 6.2 End-use Segment: Market Attractiveness Index
• 6.3 Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by End-use
• 6.4 Pharma & Bio-pharma Companies
  • 6.4.1 Pharma & Bio-pharma Companies Market Forecast by Region, 2024-2034 (US$ Million)
  • 6.4.2 Pharma & Bio-pharma Companies Market Share by Region, 2024 & 2034 (%)
• 6.5 Research & Academics
  • 6.5.1 Research & Academics Market Forecast by Region, 2024-2034 (US$ Million)
  • 6.5.2 Research & Academics Market Share by Region, 2024 & 2034 (%)
• 6.6 Others
  • 6.6.1 Others Market Forecast by Region, 2024-2034 (US$ Million)
  • 6.6.2 Others Market Share by Region, 2024 & 2034 (%)

7 Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis by Region

• 7.1 Key Findings
• 7.2 Regional Market Size Estimation and Forecast

8 North America Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

• 8.1 Key Findings
• 8.2 North America Digital Twin Technology in Pharmaceutical Manufacturing Market Attractiveness Index
• 8.3 North America Digital Twin Technology in Pharmaceutical Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
• 8.4 North America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Country
• 8.5 North America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Component
• 8.6 North America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Application
• 8.7 North America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by End-users
• 8.8 U.S. Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 8.9 Canada Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

9 Europe Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

• 9.1 Key Findings
• 9.2 Europe Digital Twin Technology in Pharmaceutical Manufacturing Market Attractiveness Index
• 9.3 Europe Digital Twin Technology in Pharmaceutical Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
• 9.4 Europe Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Country
• 9.5 Europe Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Component
• 9.6 Europe Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Application
• 9.7 Europe Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by End-users
• 9.8 Germany Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 9.9 UK Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 9.10 France Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 9.11 Italy Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 9.12 Spain Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 9.13 Russia Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 9.14 Rest of Europe Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

10 Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

• 10.1 Key Findings
• 10.2 Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market Attractiveness Index
• 10.3 Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
• 10.4 Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Country
• 10.5 Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Component
• 10.6 Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Application
• 10.7 Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by End-users
• 10.8 Japan Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 10.9 China Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 10.10 India Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 10.11 South Korea Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 10.12 Australia Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 10.13 Rest of Asia Pacific Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

11 Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

• 11.1 Key Findings
• 11.2 Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market Attractiveness Index
• 11.3 Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
• 11.4 Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Country
• 11.5 Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Component
• 11.6 Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Application
• 11.7 Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by End-users
• 11.8 Brazil Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 11.9 Mexico Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 11.10 Argentina Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 11.11 Rest of Latin America Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

12 MEA Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

• 12.1 Key Findings
• 12.2 MEA Digital Twin Technology in Pharmaceutical Manufacturing Market Attractiveness Index
• 12.3 MEA Digital Twin Technology in Pharmaceutical Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
• 12.4 MEA Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Country
• 12.5 MEA Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Component
• 12.6 MEA Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by Application
• 12.7 MEA Digital Twin Technology in Pharmaceutical Manufacturing Market Size Estimation and Forecast by End-users
• 12.8 South Africa Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 12.9 GCC Countries Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis
• 12.10 Rest of MEA Countries Digital Twin Technology in Pharmaceutical Manufacturing Market Analysis

13 Company Profiles

• 13.1 Competitive Landscape, 2023
• 13.2 Strategic Outlook
• 13.3 ATOS
  • 13.3.1 Company Snapshot
  • 13.3.2 Company Overview
  • 13.3.3 Financial Analysis
    • 13.3.3.1 Net Revenue, 2018-2023
    • 13.3.3.2 R&D, 2018-2023
    • 13.3.3.3 Regional Market Shares, 2023
    • 13.3.3.4 Business Segment Market Shares, 2023
  • 13.3.4 Product Benchmarking
  • 13.3.5 Strategic Outlook
  • 13.3.6 SWOT Analysis
• 13.4 Microsoft
  • 13.4.1 Company Snapshot
  • 13.4.2 Company Overview
  • 13.4.3 Financial Analysis
    • 13.4.3.1 Net Revenue, 2018-2023
    • 13.4.3.2 R&D, 2018-2023
    • 13.4.3.3 Regional Market Shares, 2023
    • 13.4.3.4 Business Segment Market Shares, 2023
  • 13.4.4 Product Benchmarking
  • 13.4.5 Strategic Outlook
  • 13.4.6 SWOT Analysis
• 13.5 Philips Healthcare
  • 13.5.1 Company Snapshot
  • 13.5.2 Company Overview
  • 13.5.3 Financial Analysis
    • 13.5.3.1 Net Revenue, 2018-2023
    • 13.5.3.2 R&D, 2018-2023
    • 13.5.3.3 Regional Market Shares, 2023
    • 13.5.3.4 Business Segment Market Shares, 2023
  • 13.5.4 Product Benchmarking
  • 13.5.5 SWOT Analysis
• 13.6 Oracle
  • 13.6.1 Company Snapshot
  • 13.6.2 Company Overview
  • 13.6.3 Financial Analysis
    • 13.6.3.1 Net Revenue, 2018-2023
    • 13.6.3.2 R&D, 2018-2023
    • 13.6.3.3 Regional Market Shares, 2023
    • 13.6.3.4 Business Segment Market Shares, 2023
  • 13.6.4 Product Benchmarking
  • 13.6.5 Strategic Outlook
• 13.7 PTC
  • 13.7.1 Company Snapshot
  • 13.7.2 Company Overview
  • 13.7.3 Financial Analysis
    • 13.7.3.1 Net Revenue, 2018-2023
    • 13.7.3.2 R&D, 2018-2023
    • 13.7.3.3 Regional Market Shares, 2023
    • 13.7.3.4 Business Segment Market Shares, 2023
  • 13.7.4 Product Benchmarking
  • 13.7.5 Strategic Outlook
• 13.8 Verto Health
  • 13.8.1 Company Snapshot
  • 13.8.2 Company Overview
  • 13.8.3 Product Benchmarking
  • 13.8.4 Strategic Outlook
• 13.9 Dassault Systems (3DS System)
  • 13.9.1 Company Snapshot
  • 13.9.2 Company Overview
  • 13.9.3 Financial Analysis
    • 13.9.3.1 Net Revenue, 2018-2023
    • 13.9.3.2 R&D, 2018-2023
    • 13.9.3.3 Regional Market Shares, 2023
    • 13.9.3.4 Business Segment Market Shares, 2023
  • 13.9.4 Product Benchmarking
  • 13.9.5 Strategic Outlook
• 13.10 ThoughtWire
  • 13.10.1 Company Snapshot
  • 13.10.2 Company Overview
  • 13.10.3 Product Benchmarking
• 13.11 Faststream Technologies
  • 13.11.1 Company Snapshot
  • 13.11.2 Company Overview
  • 13.11.3 Product Benchmarking
  • 13.11.4 Strategic Outlook
• 13.12 Twin Health
  • 13.12.1 Company Snapshot
  • 13.12.2 Company Overview
  • 13.12.3 Product Benchmarking
• 13.13 Siemens Healthineers AG
  • 13.13.1 Company Snapshot
  • 13.13.2 Company Overview
  • 13.13.3 Financial Analysis
    • 13.13.3.1 Net Revenue, 2018-2023
    • 13.13.3.2 R&D, 2018-2023
    • 13.13.3.3 Regional Market Shares, 2023
    • 13.13.3.4 Business Segment Market Shares, 2023
  • 13.13.4 Product Benchmarking
  • 13.13.5 Strategic Outlook
  • 13.13.6 SWOT Analysis
• 13.14 GE Healthcare
  • 13.14.1 Company Snapshot
  • 13.14.2 Company Overview
  • 13.14.3 Financial Analysis
    • 13.14.3.1 Net Revenue, 2018-2023
    • 13.14.3.2 R&D, 2018-2023
    • 13.14.3.3 Regional Market Shares, 2023
    • 13.14.3.4 Business Segment Market Shares, 2023
  • 13.14.4 Product Benchmarking
  • 13.14.5 Strategic Outlook
  • 13.14.6 SWOT Analysis
• 13.15 ANSYS, INC.
  • 13.15.1 Company Snapshot
  • 13.15.2 Company Overview
  • 13.15.3 Financial Analysis
    • 13.15.3.1 Net Revenue, 2018-2023
    • 13.15.3.2 R&D, 2018-2023
    • 13.15.3.3 Regional Market Shares, 2023
    • 13.15.3.4 Business Segment Market Shares, 2023
  • 13.15.4 Product Benchmarking
  • 13.15.5 Strategic Outlook
• 13.16 NVIDIA
  • 13.16.1 Company Snapshot
  • 13.16.2 Company Overview
  • 13.16.3 Financial Analysis
    • 13.16.3.1 Net Revenue, 2018-2023
    • 13.16.3.2 R&D, 2018-2023
    • 13.16.3.3 Regional Market Shares, 2023
    • 13.16.3.4 Business Segment Market Shares, 2023
  • 13.16.4 Product Benchmarking

14 Conclusion and Recommendations

• 14.1 Concluding Remarks from Visiongain
• 14.2 Recommendations for Market Players